Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocin to prevent neuropathy in multiple myeloma
NCT01283997Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2011
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of minocycline in peripheral neuropathy, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Difference Between Touch Detection Thresholds From the Sensorimotor Evaluation at 10 weeks. Started Jan 2011; status: completed.
02
Drugs
minocycline
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT01283997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283997.